Bank of Montreal
MACK

Bank of Montreal’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Bank of Montreal’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,640
Closed -$16K – 4444
2017
Q2 		$16K Hold
1,640
– – ﹤0.01% 3613
2017
Q1 		$40K Buy
1,640
+39
+2% +$976 ﹤0.01% 3163
2016
Q4 		$69K Buy
1,601
+139
+10% +$5.93K ﹤0.01% 2999
2016
Q3 		$73K Buy
+1,462
New +$60.7K ﹤0.01% 2926

Other funds holding MACK

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
WIM
Wittenberg Investment Management Carlisle, Massachusetts $269M AUM 28.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of Montreal's MACK Position: Q2 2018 in Review

Bank of Montreal sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q2 2018, closing a stake of 736 shares — an estimated $5K sold.

Bank of Montreal first reported a position in MACK in Q2 2013 and held it in 20 quarters. The position peaked at $144K in Q3 2016. 76 funds tracked by Wall St. Rank hold MACK as of Q2 2018.

  • Bank of Montreal reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q2 2018 after selling out during the quarter.
  • Bank of Montreal sold 736 Merrimack Pharmaceuticals, Inc. shares in Q2 2018, an estimated $5K.
  • Bank of Montreal first reported a position in Merrimack Pharmaceuticals, Inc. in Q2 2013 and held it in 20 quarters.
  • Bank of Montreal's Merrimack Pharmaceuticals, Inc. position peaked at $144K in Q3 2016.
  • 76 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q2 2018.

Based on Bank of Montreal's 13F filing for Q2 2018, filed 16 Jul 2018.